Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
BMJ Open ; 8(2): e019232, 2018 02 01.
Article in English | MEDLINE | ID: mdl-29391381

ABSTRACT

OBJECTIVE: Quantitative studies have shown the various benefits for having accreditation in hospitals. However, neither of these explored the general conditions before applying for an accreditation. To close this gap, this study aimed to investigate the possible association between joining an accreditation programme with various hospital characteristics. DESIGN: A cross-sectional study was implemented using the databases of the 2013 Hungarian hospital survey and of the Hungarian State Treasury. SETTING: Public general hospitals in Hungary. PARTICIPANTS: The analysis involved 44 public general hospitals, 14 of which joined the preparatory project for a newly developed accreditation programme. MAIN OUTCOME MEASURES: The outcomes included the percentage of compliance in quality management, patient information and identification, internal professional regulation, safe surgery, pressure sore prevention, infection control, the opinions of the heads of quality management regarding the usefulness of quality management and clinical audits, and finally, the total debt of the hospital per bed and per discharged patient. RESULTS: According to our findings, the general hospitals joining the preparatory project of the accreditation programme performed better in four of the six investigated activities, the head of quality management had a better opinion on the usefulness of quality management, and both the debt per bed number and the debt per discharged patient were lower than those who did not join. However, no statistically significant differences between the two groups were found in any of the examined outcomes. CONCLUSIONS: The findings suggest that hospitals applying for an accreditation programme do not differ significantly in characteristics from those which did not apply. This means that if in the future the accredited hospitals become better than other hospitals, then the improvement could be solely contributed to the accreditation.


Subject(s)
Accreditation , Guideline Adherence , Hospitals, Public , Quality Assurance, Health Care/standards , Quality of Health Care/standards , Accreditation/standards , Cross-Sectional Studies , Hospitals, Public/standards , Humans , Hungary , Organizational Objectives , Outcome Assessment, Health Care/standards , Quality Assurance, Health Care/organization & administration
2.
Int J Qual Health Care ; 29(2): 283-289, 2017 Apr 01.
Article in English | MEDLINE | ID: mdl-28340107

ABSTRACT

OBJECTIVE: To investigate how International Organization for Standardization (ISO) 9001 and the Hungarian Health Care Standards (HHCS) certifications are associated with quality management, patient safety, patient rights and human resource management activities. DESIGN: A cross-sectional study was implemented using the 2009 Hungarian hospital survey's database. SETTING: Hungary. PARTICIPANTS: Fifty-three general hospitals were included in the statistical analysis. INTERVENTION: No intervention was carried out in the study. MAIN OUTCOME MEASURES: The outcomes included the percentage of compliance in the dimensions of quality management, patient safety, patient rights, human resource management and the overall score for each hospital, and they were grouped according to the hospitals' certifications. RESULTS: Sixteen hospitals did not have either ISO 9001 or HHCS certifications, 19 had ISO 9001 certification only and 18 had both. Hospitals with ISO 9001 alone or in combination with the HHCS significantly outperformed hospitals with no certifications in terms of quality management and human resource management activities but not in terms of patient safety or patient rights activities. Combined, the two models provided the highest median levels in all cases. Nevertheless, no significant differences were observed when the hospitals with both certifications were compared with hospitals with ISO 9001 only. CONCLUSIONS: Although the combination of ISO 9001 and the HHCS showed the best results, the benefits were not decisive. Furthermore, although the HHCS include standards addressing patient safety, no direct association was found with regard to compliance. Thus, further investigation is required to understand this enigma.


Subject(s)
Accreditation , Hospitals/standards , Quality Assurance, Health Care/methods , Cross-Sectional Studies , Guideline Adherence , Hospital Administration , Humans , Hungary , Patient Rights/standards , Patient Safety/standards , Quality Assurance, Health Care/organization & administration , Staff Development , Workforce
3.
Gynecol Endocrinol ; 33(1): 34-38, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27468791

ABSTRACT

The aim of this study was to utilize various insulin resistance measuring methods to determine whether insulin resistance and other parameters impact the serum lipid levels of polycystic ovary syndrome (PCOS) patients and how the serum lipid levels in these patients are affected by the body mass index (BMI). Our dataset included patients between the ages of 16 and 42 (N = 228) from the outpatient endocrinology clinic of the Department of Obstetrics and Gynecology, who demonstrated increased hair growth and bleeding disorders and came for a routine oral glucose tolerance test (OGTT). Differences in the serum lipid levels were evaluated by t-test and linear regression analysis after adjusting for BMI. A stepwise regression model was constructed to evaluate the influence of each variable on the lipid levels. In PCOS patients, we found that dyslipidemia is more prevalent among hyperinsulinemic women compared with normoinsulinemic women, even after normalizing for BMI. PCOS patients with insulin resistance, determined by the insulin sensitivity index (ISI) method, showed more significant lipid abnormalities such as low high-density lipoprotein (HDL) and apo-A levels and high total cholesterol, low-density lipoprotein (LDL) and apo-B levels than if insulin resistance (IR) determination was based on insulin level or homeostatic model assessment (HOMA).


Subject(s)
Cardiovascular Diseases/blood , Hyperinsulinism/blood , Insulin Resistance , Obesity/blood , Polycystic Ovary Syndrome/blood , Adult , Cardiovascular Diseases/epidemiology , Female , Humans , Hyperinsulinism/epidemiology , Obesity/epidemiology , Polycystic Ovary Syndrome/epidemiology , Risk Factors , Young Adult
4.
Orv Hetil ; 156(50): 2018-26, 2015 Dec 13.
Article in Hungarian | MEDLINE | ID: mdl-26639643

ABSTRACT

Polycystic ovary syndrome is the most common hormonal and metabolic disorder likely to affect women. The syndrome is often associated with obesity, hyperinsulinemia and adversely affects endocrine, metabolic, and cardiovascular health. The complex feature of the syndrome requires an interdisciplinary approach to treatment, where cooperation of paediatrician, internist, gynaecologist, endocrinologist, dermatologist, psychologist and oncologist is essential. The prevention and the treatment should be based on the best available evidence. This should include physical examination, laboratory tests for hormones, serum insulin, glucose, lipids, in addition patient's preferences should be considered, too. To maximise health gain of polycystic ovarian syndrome, adequate, effective, efficient and safe treatment is necessary. This article summarises the highest available evidence provided by meta-analyses and systematic reviews of the prevention of metabolic and cardiovascular complications of the syndrome, and discusses the relevant evidence published in the literature.


Subject(s)
Biomarkers/blood , Hypoglycemic Agents/therapeutic use , Metformin/therapeutic use , Patient Care Team , Polycystic Ovary Syndrome/complications , Polycystic Ovary Syndrome/therapy , Counseling , Dermatology , Diabetes Mellitus, Type 2/etiology , Diabetes Mellitus, Type 2/prevention & control , Disease Management , Endocrinology , Evidence-Based Medicine , Female , Hirsutism/etiology , Hirsutism/therapy , Humans , Hyperinsulinism/etiology , Infertility, Female/etiology , Infertility, Female/therapy , Interdisciplinary Communication , Internal Medicine , Medical Oncology , Obesity/etiology , Obesity/prevention & control , Pediatrics , Polycystic Ovary Syndrome/blood , Polycystic Ovary Syndrome/prevention & control , Psychology , Risk Factors , Risk Reduction Behavior
5.
Orv Hetil ; 156(45): 1803-15, 2015 Nov 08.
Article in Hungarian | MEDLINE | ID: mdl-26551444

ABSTRACT

Polycystic ovary syndrome is recognized as the most common hormonal and metabolic disorder likely to affect women. The heterogeneous endocrinopathy is characterized by clinical and/or biochemical hyperandrogenism, oligo- or amenorrhoea, anovulatory infertility, and polycystic ovarian morphology. The syndrome is often associated with obesity, hyperinsulinemia and adversely affects endocrine, metabolic, and cardiovascular health. The symptoms and complaint of the patients vary with age. To maximise health gain of the syndrome, adequate, evidence based effective, efficient and safe treatment is necessary. This article summarises the highest available evidence provided by studies, meta-analysis and systematic reviews about the therapeutical possibilities for treating obesity, hyperandrogenism, menstrual abnormalities, infertility and psychological problems related to polycystic ovary syndrome.


Subject(s)
Androgen Antagonists/therapeutic use , Anti-Obesity Agents/therapeutic use , Chorionic Gonadotropin/therapeutic use , Contraceptives, Oral, Hormonal/therapeutic use , Hypoglycemic Agents/therapeutic use , Infertility, Female/therapy , Obesity/therapy , Polycystic Ovary Syndrome/therapy , Risk Reduction Behavior , Amenorrhea/drug therapy , Amenorrhea/etiology , Anovulation/drug therapy , Anovulation/etiology , Depression/etiology , Depression/therapy , Evidence-Based Medicine , Female , Hirsutism/drug therapy , Hirsutism/etiology , Humans , Hyperandrogenism/etiology , Hyperinsulinism/drug therapy , Hyperinsulinism/etiology , Infertility, Female/drug therapy , Infertility, Female/etiology , Infertility, Female/surgery , Insulin Resistance , Metformin/therapeutic use , Obesity/drug therapy , Obesity/etiology , Polycystic Ovary Syndrome/complications , Polycystic Ovary Syndrome/psychology , Polycystic Ovary Syndrome/surgery
6.
Orv Hetil ; 155(30): 1175-88, 2014 Jul 27.
Article in Hungarian | MEDLINE | ID: mdl-25063700

ABSTRACT

Polycystic ovary syndrome is recognized as the most common hormonal and metabolic disorder of women. This heterogeneous endocrinopathy characterized by clinical and/or biochemical hyperandrogenism, oligo- or amenorrhoea, anovulatory infertility, and polycystic ovarian morphology. The prevalence, clinical feature and the risk of co-morbidity vary depending on the accuracy of the diagnosis and the criteria used. Evidence suggests that those women are at high risk who fulfil the criteria based on National Institute of Health. The complex feature of the syndrome and the considerable practice heterogeneity that is present with regards to diagnostic testing of patients who are suspected to have polycystic ovary syndrome require an interdisciplinary, evidence-based diagnostic approach. Such a method can ensure the patient safety and the effectiveness and efficiency of the diagnosis. This paper summarises the highest available evidence provided by well-designed studies, meta-analysis and systematic reviews of the clinical feature and the clinical implications of the diagnostic criteria of polycystic ovary syndrome.


Subject(s)
Interdisciplinary Communication , Patient Care Team , Polycystic Ovary Syndrome/diagnosis , Polycystic Ovary Syndrome/metabolism , Carbohydrate Metabolism , Cardiovascular Diseases/etiology , Evidence-Based Medicine , Female , Genital Diseases, Female/etiology , Hirsutism/etiology , Humans , Hyperandrogenism/diagnosis , Hyperandrogenism/etiology , Lipid Metabolism , Metabolic Syndrome/diagnosis , Metabolic Syndrome/etiology , Obesity/diagnosis , Obesity/etiology , Polycystic Ovary Syndrome/complications , Polycystic Ovary Syndrome/psychology , Quality of Life
7.
Orv Hetil ; 153(4): 137-43, 2012 Jan 29.
Article in Hungarian | MEDLINE | ID: mdl-22257510

ABSTRACT

For assuring and improving quality of healthcare, everyday medical practice should be based on appropriate scientific evidence and results of health technology assessment. Evidence-based medicine is the integration of clinical expertise, patient values, and the best evidence into the decision making process for patient care, when health technologies are used. On one hand health technologies which proved to be effective should be available for all patients, on the other hand, because of the limited financial resources of the health care system, they should be cost-effective, not to spend on interventions proved to be ineffective or even harmful. For effective implementation of evidence-based practice, development of more clinical guidelines, that contain explicit recommendations, and improvement of quality approach are necessary in Hungary.


Subject(s)
Delivery of Health Care/standards , Evidence-Based Medicine , Quality Assurance, Health Care , Quality Improvement , Humans , Hungary , Quality Assurance, Health Care/organization & administration , Quality Assurance, Health Care/standards , Quality Assurance, Health Care/trends , Quality Improvement/organization & administration , Quality Improvement/standards , Quality Improvement/trends
8.
Orv Hetil ; 153(3): 83-92, 2012 Jan 22.
Article in Hungarian | MEDLINE | ID: mdl-22236414

ABSTRACT

In Hungary, financing of healthcare has decreased relative to the GDP, while the health status of the population is still ranks among the worst in the European Union. Since healthcare financing is not expected to increase, the number of practicing doctors per capita is continuously decreasing. In the coming years, it is an important question that in this situation what methods can be used to prevent further deterioration of the health status of the Hungarian population, and within this is the role of the quality approach, and different methods of quality management. In the present and the forthcoming two articles those standpoints will be summarized which support the need for the integration of quality assurance in the everyday medical practice. In the first part the importance of quality thinking, quality management, quality assurance, necessity of quality measurement and improvement, furthermore, advantages of the quality systems will be discussed.


Subject(s)
Clinical Medicine/standards , Health Expenditures , Health Status , Physicians/supply & distribution , Quality Assurance, Health Care , Quality Improvement , Quality Indicators, Health Care , European Union , Financing, Government/trends , Health Expenditures/trends , Health Status Indicators , Humans , Hungary , Mortality/trends , Outcome and Process Assessment, Health Care , Quality Assurance, Health Care/economics , Quality Improvement/economics
9.
Orv Hetil ; 153(5): 174-83, 2012 Feb 05.
Article in Hungarian | MEDLINE | ID: mdl-22275732

ABSTRACT

The first two articles in the series were about the definition of quality in healthcare, the quality approach, the importance of quality assurance, the advantages of quality management systems and the basic concepts and necessity of evidence based medicine. In the third article the importance and basic steps of clinical audit are summarised. Clinical audit is an integral part of quality assurance and quality improvement in healthcare, that is the responsibility of any practitioner involved in medical practice. Clinical audit principally measures the clinical practice against clinical guidelines, protocols and other professional standards, and sometimes induces changes to ensure that all patients receive care according to principles of the best practice. The clinical audit can be defined also as a quality improvement process that seeks to identify areas for service improvement, develop and carry out plans and actions to improve medical activity and then by re-audit to ensure that these changes have an effect. Therefore, its aims are both to stimulate quality improvement interventions and to assess their impact in order to develop clinical effectiveness. At the end of the article key points of quality assurance and improvement in medical practice are summarised.


Subject(s)
Delivery of Health Care/standards , Medical Audit , Quality Assurance, Health Care , Quality Improvement , Evidence-Based Medicine , Humans , Hungary , Medical Audit/methods , Medical Audit/organization & administration , Outcome and Process Assessment, Health Care/methods , Outcome and Process Assessment, Health Care/organization & administration , Total Quality Management
10.
Gynecol Endocrinol ; 25(6): 410-2, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19340667

ABSTRACT

We report the case of a 39-year-old Hungarian woman who cyclically experienced painful, erythematous, patchy skin lesions on her face and chest. Because of her irregular menses and hysterectomy performed later on to manage endometriosis, it was difficult to link her symptoms to the menstrual cycle. But on the basis of the cyclic nature of the rash and the previous negative results - acne vulgaris, psoriasis, atopic dermatitis, lichen planus, systemic lupus erythematosus and infections were ruled out - autoimmune progesterone dermatitis was suspected. As progesterone is not available in aqueous solution for intradermal allergen test in Hungary, we performed progesterone provocation vaginally. The patient developed the usual skin lesions to vaginal progesterone exposure, which confirmed the diagnosis. The patient became symptom free to gonadotropine-analogue treatment and remained so even after the cessation of the therapy after 6 months. To our knowledge, this is the first case in the medical literature, in which autoimmune progesterone dermatitis was proved by vaginal progesterone provocation.


Subject(s)
Autoimmune Diseases/diagnosis , Dermatitis/diagnosis , Progesterone/immunology , Administration, Intravaginal , Adult , Female , Humans , Hysterectomy
SELECTION OF CITATIONS
SEARCH DETAIL
...